Adell Harriman & Carpenter Inc. Has $15.31 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

Adell Harriman & Carpenter Inc. decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 4.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,267 shares of the healthcare conglomerate’s stock after selling 1,422 shares during the period. UnitedHealth Group comprises approximately 1.1% of Adell Harriman & Carpenter Inc.’s holdings, making the stock its 24th largest holding. Adell Harriman & Carpenter Inc.’s holdings in UnitedHealth Group were worth $15,311,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. AMF Tjanstepension AB lifted its holdings in shares of UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after acquiring an additional 121,180 shares during the period. Hudson Value Partners LLC raised its stake in UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after acquiring an additional 82 shares in the last quarter. Wealth Group Ltd. boosted its stake in shares of UnitedHealth Group by 4.0% in the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock valued at $1,039,000 after purchasing an additional 68 shares in the last quarter. Creative Planning increased its position in shares of UnitedHealth Group by 11.0% during the 3rd quarter. Creative Planning now owns 212,295 shares of the healthcare conglomerate’s stock worth $123,025,000 after purchasing an additional 21,114 shares in the last quarter. Finally, Good Life Advisors LLC grew its stake in UnitedHealth Group by 50.6% during the third quarter. Good Life Advisors LLC now owns 1,545 shares of the healthcare conglomerate’s stock worth $903,000 after buying an additional 519 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.33% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently commented on UNH shares. Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. KeyCorp reissued an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Trading Down 1.4 %

UNH opened at $523.48 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The firm’s fifty day moving average is $523.63 and its two-hundred day moving average is $563.48. The firm has a market cap of $481.75 billion, a PE ratio of 33.77, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the company earned $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.